ES2098730T3 - Derivados de hidrazida de 3,4-dihidro-2h-1-benzopiranos. - Google Patents

Derivados de hidrazida de 3,4-dihidro-2h-1-benzopiranos.

Info

Publication number
ES2098730T3
ES2098730T3 ES93907486T ES93907486T ES2098730T3 ES 2098730 T3 ES2098730 T3 ES 2098730T3 ES 93907486 T ES93907486 T ES 93907486T ES 93907486 T ES93907486 T ES 93907486T ES 2098730 T3 ES2098730 T3 ES 2098730T3
Authority
ES
Spain
Prior art keywords
alkyl
free radical
benzopyranes
dihydro
hydrazide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93907486T
Other languages
English (en)
Spanish (es)
Inventor
J Martin Grisar
Margaret A Petty
Frank Bolkenius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2098730T3 publication Critical patent/ES2098730T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
ES93907486T 1992-04-07 1993-03-12 Derivados de hidrazida de 3,4-dihidro-2h-1-benzopiranos. Expired - Lifetime ES2098730T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92400972 1992-04-07

Publications (1)

Publication Number Publication Date
ES2098730T3 true ES2098730T3 (es) 1997-05-01

Family

ID=8211648

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93907486T Expired - Lifetime ES2098730T3 (es) 1992-04-07 1993-03-12 Derivados de hidrazida de 3,4-dihidro-2h-1-benzopiranos.

Country Status (19)

Country Link
EP (1) EP0635011B1 (index.php)
JP (1) JP3226174B2 (index.php)
KR (1) KR950700680A (index.php)
AT (1) ATE146466T1 (index.php)
AU (1) AU675784B2 (index.php)
CA (1) CA2132831C (index.php)
DE (1) DE69306770T2 (index.php)
DK (1) DK0635011T3 (index.php)
ES (1) ES2098730T3 (index.php)
FI (1) FI944678A7 (index.php)
GR (1) GR3022122T3 (index.php)
HU (1) HU215912B (index.php)
IL (1) IL105319A (index.php)
MX (1) MX9301979A (index.php)
NO (1) NO943760L (index.php)
NZ (1) NZ251174A (index.php)
TW (1) TW278076B (index.php)
WO (1) WO1993020059A1 (index.php)
ZA (1) ZA932414B (index.php)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510373A (en) * 1992-04-06 1996-04-23 Merrell Pharmaceuticals Inc. Cardioprotective agents
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010505A1 (de) * 1980-03-19 1981-10-01 Basf Ag, 6700 Ludwigshafen Chromanderivate, verfahren zu ihrer herstellung, ihre verwendung als stabilisatoren von organischen materialien sowie diese stabilisatoren enthaltende organische materialien
CA1338012C (en) * 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
EP0369083A1 (en) * 1988-11-14 1990-05-23 Merrell Dow Pharmaceuticals Inc. Cardioprotective tocopherol analogs
EP0412939A3 (en) * 1989-08-11 1991-09-04 Ciba-Geigy Ag Certain benzopyran and benzothiopyran derivatives
DE4000397A1 (de) * 1990-01-09 1991-07-11 Hoechst Ag Lipidselektive antioxidantien sowie deren herstellung und verwendung
KR900016822A (ko) * 1990-04-20 1990-11-14 하라 레이노스께 슬라이드 프로젝터

Also Published As

Publication number Publication date
EP0635011B1 (en) 1996-12-18
FI944678A0 (fi) 1994-10-06
WO1993020059A1 (en) 1993-10-14
CA2132831A1 (en) 1993-10-14
DE69306770D1 (de) 1997-01-30
JPH07505625A (ja) 1995-06-22
HU215912B (hu) 1999-03-29
DE69306770T2 (de) 1997-06-12
NZ251174A (en) 1996-01-26
TW278076B (index.php) 1996-06-11
MX9301979A (es) 1993-11-01
ZA932414B (en) 1993-10-22
GR3022122T3 (en) 1997-03-31
IL105319A (en) 1998-02-22
AU675784B2 (en) 1997-02-20
HUT68833A (en) 1995-08-28
HU9402882D0 (en) 1995-01-30
DK0635011T3 (da) 1997-01-06
EP0635011A1 (en) 1995-01-25
NO943760L (no) 1994-12-06
FI944678L (fi) 1994-10-06
FI944678A7 (fi) 1994-10-06
ATE146466T1 (de) 1997-01-15
JP3226174B2 (ja) 2001-11-05
AU3807293A (en) 1993-11-08
NO943760D0 (no) 1994-10-06
KR950700680A (ko) 1995-02-20
IL105319A0 (en) 1993-08-18
CA2132831C (en) 1998-06-16

Similar Documents

Publication Publication Date Title
ES2123829T3 (es) Derivados de 3-(5-tetrazolil-bencil)amino-piperidina y antagonistas de las taquiquininas.
ES2055175T3 (es) Utilizacion del acido 5-metiltetrahidrofolico, del acido 5-formiltetrahidrofolico y de sus sales farmaceuticamente aceptables, para la preparacion de composiciones farmaceuticas de liberacion retardada adecuadas para la utilizacion en la terapia de trastornos depresivos, y las co
ES2109332T3 (es) Ciclopropilamino-1,3,5-triazinas sustituidas.
DK0483772T3 (da) Aminocumaranderivater, samt fremstilling og anvendelse deraf
AR009052A1 (es) Tienopirimidinas, un procedimiento para su preparacion, empleo de las mismas para preparar un medicamento, preparaciones farmaceuticas que lascontienen y un procedimiento para obtener estas preparaciones farmaceuticas
ES2083773T3 (es) Derivados de 1,3-dihidro-2h-imidazo(4,5-b)quinolin-2-ona como inhibidores de fosfodiesterasa.
ES472608A1 (es) Un procedimiento de preparacion de derivados de 4-n-acilo- fortimicina b
NO933452L (no) Et terapeutisk middel for Parkinson's sykdom
ES2082805T3 (es) Derivados de tiazol, procedimientos para su produccion y composiciones farmaceuticas que comprenden los mismos.
NO174044C (no) Analogifremgangsmåte for fremstilling av et terapeutisk aktivt amid-derivat
FI951966A0 (fi) Uudet polyeeniyhdisteet, niitä sisältävät farmaseuttiset ja kosmeettiset koostumukset ja niiden käyttö
DE59706313D1 (de) Acylierte n-hydroxymethyl thalidomid-prodrugs mit immunomodulatorischer wirkung
ES2058450T3 (es) Compuestos de quinoxalina y su preparacion y uso.
EE02950B1 (et) Metüleenbisfosfoonhappe esteramiidderivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioon
UY25211A1 (es) Inhibidores de isoquinolinilguanidina uroquinasa
ES2098730T3 (es) Derivados de hidrazida de 3,4-dihidro-2h-1-benzopiranos.
ES2031894T3 (es) Procedimiento para preparar derivados de 4(3h)-oxo-5,6,7,8-tetrahidropirido-(2,3-d)-pirimidina.
SE7706346L (sv) Bensaminderivat
FR2655545B1 (fr) Nouvelle application therapeutique des derives des fluoroquinolones.
CO4410336A1 (es) Derivados de quinoxalina utiles en terapia
ES2109988T3 (es) Derivados cefalosporinicos.
ES2122221T3 (es) Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR248127A1 (es) Procedimiento para la preparacion de nuevas 2-aminotetralinas sustituidas en la posicion 8.
ES2095434T3 (es) Nuevos derivados del 3-cicloalquil-propen-2-amida, sus formas tautomeras y sus sales, procedimiento de preparacion, aplicacion como medicamentos, y composiciones que los contienen.
ES2036178T3 (es) Procedimiento para preparar nuevas benzamidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 635011

Country of ref document: ES